Aohong Pharmaceutical Co., Ltd. is based on biochemical drugs, supplemented by traditional Chinese medicine, chemical medicine and natural medicine, and its main research and development direction is biochemical preparation, natural medicine, natural medicine monomer, compound preparation of traditional Chinese medicine and secondary research and development of traditional Chinese medicine. By developing new products, expanding the scope of indications and reforming dosage forms, a series of products will be formed, and then industrial upgrading, product strength building and brand strength building will be realized. "Aodejin" is the leading brand in the field of calf blood-removing products in China, and "Bangting" is one of the three major brands of hemocoagulase hemostatic drugs in China. In addition, Yushangling capsules, anti-hyperosteogeny tablets, Fuyankangfu tablets and other products also have a high reputation and market share in the market. Aohong Pharmaceutical adheres to the marketing concept of deepening differentiation, optimizes products and market portfolio, innovatively constructs two marketing models, prescription drugs and OTC, and always maintains a healthy, stable and developing business relationship with customers. Smooth marketing channels, excellent products and excellent services have promoted the continuous improvement of the overall brand power of Aohong Pharmaceutical.